BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 186375)

  • 1. [Changes of the renin-angiotensin-aldosterone system under contraceptive steroids. Contribution to the etiology of hypertension under hormonal contraceptives].
    Kaulhausen H; Klingsiek L; Breuer H
    Fortschr Med; 1976 Nov; 94(33):1925-30. PubMed ID: 186375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives--induced hypertension--nine years later.
    Laragh JH
    Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal contraception and hypertension].
    Hamann KM; Faulhaber HD; Hamann B
    Z Arztl Fortbild (Jena); 1982 Mar; 76(5):198-201. PubMed ID: 7080544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of arterial hypertension imputable to an estroprogestational contraceptive. Implication of the renin-angiotensin-aldosterone system].
    Fontenaille C; Camelot G; Béquart P; Boulangé M
    J Urol Nephrol (Paris); 1969 Dec; 75(12):950-5. PubMed ID: 4314141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral contraceptives and hypertension].
    Werning C; Siegenthaler W
    Schweiz Med Wochenschr; 1971 Apr; 101(15):543-4. PubMed ID: 4325189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of hormonal contraceptives on the renin-angiotensin-aldosterone system].
    Zhemerikina EV; Kiknadze MP; Uchitel' IA
    Sov Med; 1976 Oct; (10):124-6. PubMed ID: 1023365
    [No Abstract]   [Full Text] [Related]  

  • 7. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L; Shore AC; Mott V; Wilkinson R
    Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral contraceptives and arterial hypertension].
    Losse H; Risse E; Wessels F
    Med Klin; 1974 Dec; 69(50):2043-50. PubMed ID: 4374645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral contraceptive therapy on the renin-angiotensin system in normotensive and hypertensive women.
    Tapia HR; Johnson CE; Strong CG
    Obstet Gynecol; 1973 May; 41(5):643-9. PubMed ID: 4348864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin II analog on blood pressure, renin and aldosterone in women on oral contraceptives and toxemia.
    Saruta T; Nakamura R; Nagahama S; Suzuki H; Kondo K
    Gynecol Obstet Invest; 1981; 12(1):11-20. PubMed ID: 7019015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
    Weinberger MH; Kramer NJ; Grim CE; Petersen LP
    J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects of hypertension under contraceptive steroids].
    Kaulhausen H; Klingsiek L
    Fortschr Med; 1976 Dec; 94(34):2005-13. PubMed ID: 793966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of oral contraceptives on plasma renin activity and plasma renin substrate concentration (author's transl)].
    Kaulhausen H; Oehm W; Fritzsche G; Breuer H
    Z Klin Chem Klin Biochem; 1974 Sep; 12(9):408-14. PubMed ID: 4372825
    [No Abstract]   [Full Text] [Related]  

  • 16. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
    Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL
    J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
    Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
    J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension and hormonal contraceptives].
    Retzke U; Schwarz R
    Z Gesamte Inn Med; 1980 Nov; 35(21):suppl 138-41. PubMed ID: 7467595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.